Abstract
Dermatological diseases of the scalp significantly affect the life quality of people. According to statistical data, seborrheic dermatitis (SD) is the most common dermatological disease in more than 50% of the population all over the world. The medicines for treatment of SD are synthetic antimicrobial substances with high efficiency, but their regular use changes a biodiversity of scalp microflora and determines subsequent antimicrobial resistance. Therefore, the aim of study was the development of plant-based pharmaceutical substance for treatment of SD.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
